title: Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers.
abstract: Several viral factors are associated with disease progression in hepatitis B virus (HBV) carriers. Compared with Taiwanese Han Chinese, Taiwanese aborigines have a higher prevalence of chronic HBV infection and a higher standardized mortality rate of chronic liver diseases but a lower standardized mortality rate of hepatocellular carcinoma (HCC). The aim of this study was to investigate whether aboriginal Taiwanese HBV carriers have more favorable viral factors which reduce the risk for HCC than Han Chinese carriers. Blood samples from 3,488 HBV carriers (1,527 aborigines and 1,961 Han Chinese) were assayed for aminotransferases, hepatitis B e antigen (HBeAg), HBV DNA, and HBV genotype. Aboriginal HBV carriers had a lower HBeAg-positive rate (5.3% vs. 10.2%, P < 0.0001) and a lower viral load of HBV DNA > 2,000 IU/ml (27.4% vs. 36.7%, P < 0.0001) but a higher rate of alcohol consumption (40.0% vs. 19.3%, P < 0.0001) than Han Chinese carriers. The prevalence of HBV genotype B in aboriginal carriers (92.7%) was significantly higher than that in Han Chinese carriers (72.7%) in all age groups (P < 0.05). In addition, patients with rare genotype D infections were clustered in a township in southern Taiwan. In conclusion, aboriginal Taiwanese HBV carriers have more favorable viral factors than Han Chinese carriers, which may be partly responsible for the lower standardized mortality rate of HCC in Taiwanese aborigines.
authors.affiliation: Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.
authors.forename: Hsiao-Ching
authors.initials: HC
authors.lastname: Nien
authors.forename: Jin-Chuan
authors.initials: JC
authors.lastname: Sheu
authors.forename: Jia-Horng
authors.initials: JH
authors.lastname: Kao
authors.forename: Huei-Chi
authors.initials: HC
authors.lastname: Chou
authors.forename: Chien-Wen
authors.initials: CW
authors.lastname: Su
authors.forename: Chien-Hung
authors.initials: CH
authors.lastname: Chen
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology* / Q000401:mortality; D002353:Carrier State / Q000453:epidemiology* / Q000821:virology; D004279:DNA, Viral / Q000097:blood; D018450:Disease Progression; D005006:Ethnicity; D005260:Female; D005838:Genotype; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000145:classification / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity*; D019694:Hepatitis B, Chronic / Q000150:complications / Q000453:epidemiology* / Q000821:virology; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D013624:Taiwan / Q000453:epidemiology; D000637:Transaminases / Q000097:blood; D019562:Viral Load
chemical_list: D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D000637:Transaminases